|
|
Office Locations:
|
4208 Six Forks Road, Suite 920
Raleigh, NC 27609
Phone: 919-459-8620
Fax: 919-516-0580
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
NovaQuest Capital Management manages private equity and other investments in the global biopharmaceutical sector, where its principal focus is investing in late-stage clinical assets and commercial phase biopharmaceutical products. NovaQuest contracts with global biopharmaceutical corporations to invest side-by-side in their most strategic development and commercialization programs. The NovaQuest team began their work together in 2000 as the staff of a key investment group within Quintiles Transnational Corp. The firm recently raised $244.1 million for Novaquest Pharma Opportunities Fund III. NovaQuest Product Finance has committed $3.0B over 48 investments. In Biopharma the firm has $2.5+ billion in total commitments in 35+ investments.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
